RC

Renato Chirivi

Chief Technology Officer

Citryll

Oss, North Brabant


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Citryll
Industry
research
Employees
30.0
Seniority
C suite
Annual Revenue
2300000.0
Total Funding
127639734.0
Latest Funding
Series B

Technologies

Outlook Mobile Friendly Google Font API reCAPTCHA Google Tag Manager Apache WordPress.org Gravity Forms

Keywords

immunology therapeutics development neutrophil extracellular traps inflammatory diseases antibody development rheumatoid arthritis hidradenitis suppurativa biotechnology research cit-013 dual mode of action netosis investigational therapy clinical trials monoclonal antibody anti-citrullinated histone immunotherapy chronic inflammation autoimmune disorders biopharmaceutical development therapeutic areas patient quality of life phase 2a trial efficacy safety studies disease mechanism immune response inflammatory markers biotech innovation translational medicine mechanism of action selective targeting inhibition of net formation enhancement of net clearance citrullinated histones immune-mediated diseases pro-inflammatory mechanisms net-driven inflammation pharmacology drug development antibody discovery therapeutic potential research & development patient participation clinical research health outcomes novel therapeutics biotechnology immunological studies experimental rheumatology bioanalytics neutrophil activation therapeutic optimization health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans